YUTOPAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Yutopar, and when can generic versions of Yutopar launch?
Yutopar is a drug marketed by Astrazeneca and is included in two NDAs.
The generic ingredient in YUTOPAR is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
Summary for YUTOPAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 27 |
Clinical Trials: | 1 |
Patent Applications: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | YUTOPAR at DailyMed |
Recent Clinical Trials for YUTOPAR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for YUTOPAR
US Patents and Regulatory Information for YUTOPAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-002 | Sep 27, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astrazeneca | YUTOPAR | ritodrine hydrochloride | TABLET;ORAL | 018555-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for YUTOPAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-002 | Sep 27, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Astrazeneca | YUTOPAR | ritodrine hydrochloride | TABLET;ORAL | 018555-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for YUTOPAR
See the table below for patents covering YUTOPAR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 1483718 | Nouvelle aralkylamine et sa prĂ©paration | ⤷ Try a Trial |
Sweden | 339481 | ⤷ Try a Trial | |
Denmark | 116740 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |